Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases

Rheumatology (Oxford). 2013 Oct;52(10):1923-4. doi: 10.1093/rheumatology/ket130. Epub 2013 Apr 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Middle Aged
  • Receptors, Interleukin-6 / antagonists & inhibitors
  • Treatment Failure

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Receptors, Interleukin-6
  • tocilizumab